Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here

Expert drug discovery services

Our Discovery Services augment your own expertise or give you capacity when you need it. Our team of leading scientists runs bespoke drug discovery campaigns for our partners and is continually innovating to validate and utilize cutting edge technology in our discovery offerings.

Therapeutic Antibody Discovery

We offer an ever-growing stable of services and cutting-edge technology platforms to help you discover the best therapeutic antibodies in the ideal formats for your therapeutic targets.
OUR PLATFORMS AND SERVICES

Discover therapeutic antibodies in our labs or yours

We started with the ATX-Gx transgenic humanized mice platform for antibody discovery and have built a robust discovery services organization around that foundational technology, while constantly improving our capabilities to help our partners find the ideal antibodies for therapeutic intent.

ANTIBODY DISCOVERY SERVICES & PLATFORMS
ANTIBODY DISCOVERY SERVICES
ANTIBODY DISCOVERY ADD-ONS
ATX-GX TRANSGENIC MICE PLATFORM
ATX-CLC BISPECIFICS PLATFORM
FULLY INTEGRATED

Alloy Antibody Discovery Services

There are many ways to discover an antibody, but not all antibodies are created equal. We offer a precision approach to generating, retrieving, and assessing antibodies with the specific properties required for the intended therapeutic effect.

Visit Antibody Discovery Services
THROUGH ANTIBODY DISCOVERY SERVICES

ATX-CLC Platform for Bispecifics Discovery

We are continuously innovating to create new platform technology and capabilities, which are first made available through campaigns with Alloy Antibody Discovery Services. The ATX-CLC is a transgenic murine in vivo discovery platform, optimized for bispecific and multispecific human antibody-based therapeutics.

LICENSE OUR TECHNOLOGY

Our Antibody Discovery Platforms

We develop, improve, license, and share foundational, pre-competitive antibody discovery platforms for use in your lab, with your preferred CRO, or with our platform experts in Alloy Discovery Services. We have designed our licenses with flexible, affordable terms that allow our partners to easily access all our continuous platform improvements. 

IN VIVO MONOCLONAL ANTIBODY DISCOVERY

ATX-Gx Transgenic Humanized Mice

ATX-Gx™ is the world’s most popular humanized mice platform for antibody discovery, available through Alloy Antibody Discovery Services or in your lab in as little as two weeks.

Visit ATX-Gx
ACCELERATE YOUR DRUG PROGRAM

Translational medicine services

We accelerate partner programs by providing early insights into functional activity of therapeutic candidates generated from Alloy discovery programs across all modalities. Generally, we offer these services in line with DeepImmune for human antibody discovery and Keyway for therapeutic TCR discovery, but we can offer advice and services on a case-by-case basis for our license partners and ecosystem collaborators.

In vivo antibody discovery

We empower discovers of monoclonal, bispecific, and single domain antibodies with royalty-free access to our platforms.
Alloy Therapeutics humanized mouse antibody drug discovery platforms

Our first platform, the ATX-Gx™, is the world’s fastest growing transgenic mouse platform for human monoclonal antibody discovery. Partners may ship mice to their labs, work with an ATX-Gx certified service provide, or engage with our flagship antibody discovery service, DeepImmune.

ATX-Gx™

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

ATX-CLC

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

ATX-SiD

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

How can we help?

Learn more about licensing our platforms for use your lab or starting a campaign with DeepImmune.

Machine Learning

Deep learning optimized discovery

We’ve built a robust unique Deep Learning and sequencing engine that characterizes immune repertoire data, rapidly identifies novel binders, and optimizes candidates by scanning the breadth of sequence variants.

READ MORE

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

Supporting drug makers across 6 biologic modalities

We are also active in genetic medicines, peptides, cell therapy, and drug delivery technology through new Venture Studio companies, discovery services, and internal innovation projects.

antibody drug discovery
TCR drug discovery
ASO genetic medicines discovery
ANTIBODIES

TCRS

GENETIC MEDICINES
peptides drug discovery
chimeric antigen receptor drug discovery
biologics drug delivery
PEPTIDES
CELL THERAPIES
DELIVERY

Learn more about our work in these areas.

UNLIMITED TECHNOLOGY, FIXED PRICE

All-Access Innovation Subscriptions

Get unlimited access to all our current and future technology for one fixed annual fee, with no Alloy milestones or royalties.

CO-DEVELOP WITH US

Inspire us with your new technology ideas and we’ll develop them together  

We have new innovations under development across all six of our modalities. These are all available for co-development with partners of all types. As an Alloy platform development partner, you’ll access the resulting platform royalty-free, in perpetuity.

Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please read and Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound